IDEAYA Biosciences Company
IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment. IDEAYA, located in South San Francisco and La Jolla, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.
Investors
.png)
.png)
.png)
.png)
Technology:
Biotechnology, Health Care, Therapeutics
Industry:
End-to-end Drug Development
Headquarters:
South San Francisco, California, United States
Founded Date:
2015-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
16
Total Funding:
226100000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-07-07
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership